Secondly, while focused on PDE3A as a key downstream effector of IGF2BP3, we acknowledge the emerging significance of apoptotic and autophagic regulators such as BCL-2 and Beclin-1 in preeclampsia and HELLP syndrome [33]. This evidence concerns the gene IGF2BP3 and preeclampsia.